Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

Genetic Technologies Announced Earlier Upcoming Launch Of World’s First Comprehensive Risk Test For Breast & Ovarian Cancer

By Charles Gross
February 2, 8:03 PM
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce the Company will launch a ‘World First' Comprehensive Risk Assessment Test which evaluates a women's risk of developing Breast and/or Ovarian Cancer either from a hereditary genetic mutation or from the far more common familial or sporadic cancer.

GENE

Read More
1 minute read

Vera Vera Therapeutics Late Wednesday Announced Pricing Of ~!4.28M Share Public Offering of Class A Common Stock @$7/Share

By Charles Gross
February 2, 6:11 AM
Vera Therapeutics, Inc., (NasdaqGM: VERA) announced the pricing of its previously announced underwritten public offering of 14,285,715 shares of its Class A common stock at a price to the public of $7.00 per share. The gross proceeds to Vera from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $100.0 million.

VERA